Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | ABBV | TMO |
|---|
| Close | 294.89 | 697.00 |
| Market Cap | $522B | $258B |
| 1M | +12.73% | +3.25% |
| P/E (TTM) | 81.4 | 36.4 |
| Forward P/E | 16.9 | 24.6 |
| P/E 5-Yr Percentile | 62 | 78 |
| P/S | 8.0 | 5.4 |
| P/B | — | 4.7 |
| Dividend Yield | 4.47% | 0.29% |
| Latest Quarter Revenue | $17.0B | $12.1B |
| Revenue YoY | +10.2% | +9.1% |
| Gross Margin | 74.7% | — |
| Latest Quarter EPS | 2.03 | 4.64 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 1.82% |
| 90-Day Net Insider Buying | −$8.2M | −$40.3M |
ABBV · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
